摘要:
The present invention relates to novel heterocyclic compounds of general formula (I) their tautomers, stereoisomers, enantiomers, pharmaceutically acceptable salts and pharmaceutical composition. The compounds of general formula (I) belongs to the family of NOD like receptor family (NLR) protein NLRP3 modulators. The present invention thus relates to novel NLRP3 modulators and use of these novel inhibitor compounds in the treatment of disease or conditions as well as treatment of disease states mediated by NLRP3 as well as treatment of diseases or conditions in which interleukin 1β activity and interleukin-18 (IL-18) is implicated.
摘要:
La présente invention a pour objet un inhalateur nasal comprenant à titre de substances actives, au moins du camphre et de l'eucalyptus ou un composé bioéquivalent de ces derniers pour aider à soulager les symptômes liés aux infections des voies respiratoires supérieures.
摘要:
The present invention relates to compositions and in particular to compositions for treating a skin or mucosal membrane infection. In some embodiments, the present invention relates to a composition suitable for treating a skin or mucosal membrane infection the composition comprising glycerol, at least one surfactant, an alcohol, a terpene or terpenoid compound, and a copper compound.
摘要:
The invention concerns use of a composition for the treatment and prophylaxis of an influenza infection in a mammal. The composition comprises a mixture of 30% - 80% of at least one compound having the formula and 10% to 40% of at least one compound of the formula wherein the substituents are as defined in the description. The invention also relates to methods for the treatment and prophylaxis of an influenza infection and also use of the composition in the preparation of a medicament for the treatment and prophylaxis of an influenza infection in a mammal.
摘要:
A composition having bactericidal properties comprising; (a) 30% - 80% of at least one compound having the formula (I) and (b) 10% to 40% of at least one compound of formula (II)
摘要:
A fungus treatment composition used to deliver active drugs trans-nail as well as a method for producing the fungus treatment composition, which may contain up to 50% additive ingredients. Preferred embodiments of the invention may include fungus treatment compositions which provide high nail penetrating power, which have antifungal agents, which have antifungal essential oils, which have optimum drying and barrier properties, which have pharmaceutically elegant properties, or most preferably an embodiment having a total combination thereof.
摘要:
The invention relates to the chemical and pharmaceutical industry, in particular to a drug for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and to a method for the use thereof. The inventive drug is based on dextrorotary (D) or levogeratory (L) or racemic (DL) camphor in the form of a fatty-oil-dimexide emulsion (Emulsio Camphorae Axungio Oleo-Dimexidosa), an oil-aqueous emulsion (Emulsio Camphorae Oleo-Aguosa) or in the form of suppositories, the camphor quantity being of 0.1-15.0 % by volume. The above-listed drugs are rectally administrable once a day by course of therapy upto 20 days every year. The camphor preparations increase the resistance of tissue colloids, exhibit antagonistic action with respect to capillary poisons, activate the erection center of the sacral part of the parasympathetic nervous system, exhibit M- and H-cholinolytic action, produce tonic action on the ejaculation center situated in the symphatic part of the central nervous system, normalise the capillary and venule tonus, stimulate vasomotor centers of the spinal chord, enhance the synthesis of macroergic phosphates and inhibit ATPacid splitting in the hypoxia conditions and exhibit analgesic, bactericidal and fibrinolytic effect. The inventive drug and method make it possible to carry out the preventive treatment of the above-listed disease during many decades.
摘要:
Die vorliegende Erfindung betrifft Nano-Vehikel zum verbesserten transkutanen Transport, insbesondere von pharmakologisch aktiven Wirkstoffen. Die Vehikel umfassen ein oder mehrere Mittel mit an sich hautreizender Wirkung bzw. lokalanästhetischer Wirkung. Damit können überraschender Weise Wirkstoffe, insbesondere in Form von Mikro-Emulsionen, verbessert lokal / topisch transportiert werden, obgleich eine derartige Wirk-Kombination das Gegenteil hätte vermuten lassen. Eine verbesserte transkutane Anwendung kann vor allem zu lokal sonst nicht zu erreichenden Wirkstoffkonzentrationen sowie zu einer verkürzten Anwendungszeit und damit langfristig zu einer erheblichen Reduzierung von Nebenwirkungen führen. Je nach aktivem Wirkstoff können somit pharmakologische, insbesondere dermatologische Zubereitungen z. B. bei entzündlichen/ schmerzhaften Zuständen von Haut / Unterhautgewebe bei Säugern hergestellt und angewendet werden.
摘要:
New topical medicaments are provided. The medicaments comprise menthol and camphor, preferably provided as part of a base gel, supplemented with potassium and a source of oxygen. The most preferred base gel is sold under the name SOMBRA, while the most preferred source of oxygen is a chlorite (e.g., sodium chlorite) and/or spirulina. The medicaments provide high metabolic activities and sustain those activities over prolonged periods of time, thus being useful for treating a large variety of aliments, including diabetic neuropathy, post hepatic neuralgia, sclerodema, psoriasis, strain, spasticity, headaches, neuropathy secondary to drugs, peripheral neuropathy, leg pain, muscle cramps, muscle aches and pains, bruise, sinusitis, sprain, arthritis, joint pain (arthralgia), and edema.